Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Jade Biosciences, Inc. (NASDAQ:JBIO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, six have assigned a buy recommendation […]
11 Aug 08:45 · The Markets Daily